Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03152188 · ClinicalTrials.gov registry record · Phase 1
Oral Fecal Transplant in Cirrhosis
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT03152188 is a Phase 1 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 20 participants.
The verdict
NCT03152188, a Phase 1 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
To evaluate the safety and tolerability of oral fecal transplant in patients with cirrhosis and hepatic encephalopathy
Interventions
- OTHER Placebo
- DRUG FMT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-06-12 |
| Est. Completion | 2018-11-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03152188
The ClinicalTrials.gov registry entry for NCT03152188 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03152188 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03152188 about?
NCT03152188 is a clinical study titled "Oral Fecal Transplant in Cirrhosis". To evaluate the safety and tolerability of oral fecal transplant in patients with cirrhosis and hepatic encephalopathy
What is the current status of trial NCT03152188?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2017-06-12. Estimated completion is 2018-11-12.
What interventions are being tested in trial NCT03152188?
The interventions under investigation include: Placebo (OTHER), FMT (DRUG).
Who is sponsoring clinical trial NCT03152188?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.